Topical makes the most sense for: Facial skin texture, fine lines, hydration Scalp application for localized hair growth Scar treatment or post-procedure recovery on a specific area Patients who want to fold GHK-Cu into an existing skincare routine Injectable makes the most sense for: Systemic wound healing (especially internal or in areas you can't easily apply cream) Joint and connective tissue support (topical simply can't penetrate deep enough) Broader anti-aging goals beyond the skin surface Patients already running other injectable peptide protocols (CJC-1295/ipamorelin, BPC-157, TB-500) Here's the thing: for joints specifically, there's no argument
#IowaPath @AllenChoiMD Acetaminophen toxicity is treated with n-acetylcysteine (NAC), which provides a source of cysteine for de novo synthesis of glutathione (GSH)
Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor
The lethal toxin from Australian funnel-web spiders is encoded by an intronless gene
These results might have contributed to symptom relief and an increase in the number of survival days (Fig
Why "fat burner" framing doesn't hold up An accurate fat-loss tool typically influences at least one of these directly: Appetite and satiety regulation Energy expenditure/thermogenesis Lipolysis and fat oxidation pathways Glucose regulation in a clinically meaningful way BPC-157 has not been established as reliably effective in humans for those categories of fat loss